SCHEMBL10017633

SCHEMBL10017633

C=CCOc1c(Cl)cc(Cl)cc1C=C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
CXCR5 P32302 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
GAA P10253 2/20 0.36
TSHR P16473 2/20 0.36
CCR5 P51681 1/20 0.36
ORAI1 Q96D31 1/20 0.36
LMNA P02545 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ERN1 O75460 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
HPGD P15428 2/20 0.34
ALOX12 P18054 1/20 0.34
PKM P14618 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11541914 0.87 HSD17B10 (0.46) HSD17B10CXCR5MEN1KMT2AALDH1A1
SCHEMBL5881855 0.86 ORAI1 (0.49) HSD17B10CXCR5MEN1KMT2AALDH1A1
SCHEMBL10017630 0.82 GAA (0.35) HSD17B10CXCR5MEN1KMT2AALDH1A1
SCHEMBL4432897 0.79 HSD17B10 (0.41) HSD17B10CXCR5MEN1KMT2AALDH1A1
SCHEMBL13928781 0.72 HSD17B10 (0.40) HSD17B10CXCR5MEN1KMT2AALDH1A1
SCHEMBL10642511 0.72 HSD17B10 (0.44) HSD17B10MEN1KMT2AALDH1A1MAPT
SCHEMBL31006518 0.70 HSD17B10 (0.57) HSD17B10CXCR5MEN1KMT2AALDH1A1
SCHEMBL24644599 0.70 GAA (0.33) HSD17B10MEN1KMT2AALDH1A1GAA
SCHEMBL16533511 0.69 HSD17B10 (0.35) HSD17B10MEN1KMT2AALDH1A1MAPT
SCHEMBL5917949 0.69 HSD17B10 (0.35) HSD17B10MEN1KMT2AGAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2886549-A1 Ruthenium complex ligand, ruthenium complex and the use of the complex as a catalyst in olefin metathesis reactions Zannan Scitech Co., Ltd. (CN) 2015-06-24 EP disclosed
EP-1905777-B1 RUTHENIUM COMPLEX LIGAND, RUTHENIUM COMPLEX, CARRIED RUTHENIUM COMPLEX CATALYST AND THE PREPARING METHODS AND THE USE THEREOF ZANNAN SCITECH CO LTD (CN) 2015-05-06 EP disclosed
US-8288576-B2 Recyclable ruthenium catalysts for metathesis reactions ZANNAN SCITECH CO., LTD. (CN) 2012-10-16 US disclosed
US-8288576-B2 Recyclable ruthenium catalysts for metathesis reactions ZANNAN SCITECH CO., LTD. (CN) 2012-10-16 US disclosed
US-20120016093-A1 RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS ZANNAN SCITECH CO., LTD. (CN) 2012-01-19 US disclosed
US-20120016093-A1 RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS ZANNAN SCITECH CO., LTD. (CN) 2012-01-19 US disclosed
US-8049025-B2 Recyclable ruthenium catalysts for metathesis reactions ZANNAN SCITECH CO., LTD. (CN) 2011-11-01 US disclosed
US-8049025-B2 Recyclable ruthenium catalysts for metathesis reactions ZANNAN SCITECH CO., LTD. (CN) 2011-11-01 US disclosed
US-20100041844-A1 RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS ZHENG-YUN JAMES ZHAN (CN) 2010-02-18 US disclosed
US-20100041844-A1 RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS ZHENG-YUN JAMES ZHAN (CN) 2010-02-18 US disclosed
US-7632772-B2 Recyclable ruthenium catalysts for metathesis reactions Zhan, Zheng-Yun James (CN) 2009-12-15 US disclosed
US-7632772-B2 Recyclable ruthenium catalysts for metathesis reactions Zhan, Zheng-Yun James (CN) 2009-12-15 US disclosed
EP-1905777-A1 RUTHENIUM COMPLEX LIGAND, RUTHENIUM COMPLEX, CARRIED RUTHENIUM COMPLEX CATALYST AND THE PREPARING METHODS AND THE USE THEREOF Zhan, Zheng-Yun (CN) 2008-04-02 EP disclosed
US-20070043180-A1 Recyclable ruthenium catalysts for metathesis reactions ZHENG-YUN JAMES ZHAN (CN) 2007-02-22 US disclosed
US-20070043180-A1 Recyclable ruthenium catalysts for metathesis reactions ZHENG-YUN JAMES ZHAN (CN) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016093-A1 RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS RPIA, REV1, RCSD1 HSD17B10 2790/4885CXCR5 1077/4885MEN1 4261/4885
US-20100041844-A1 RECYCLABLE RUTHENIUM CATALYSTS FOR METATHESIS REACTIONS RPIA, REV1, RCSD1 HSD17B10 2790/4885CXCR5 1077/4885MEN1 4261/4885
US-20070043180-A1 Recyclable ruthenium catalysts for metathesis reactions RPIA, REV1, RCSD1 HSD17B10 2790/4885CXCR5 1077/4885MEN1 4261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.